Sturgess
R, et al. Wheat peptide challenge in coeliac disease. Lancet. 1994
Mar 26;343(8900):758-61.
Fluge O, et al. In vitro toxicity of purified gluten peptides
tested by organ culture. J Pediatr Gastroenterol Nutr. 1994 Feb;18(2):186-92.
Wieser H. Relation between gliadin structure and coeliac toxicity.
Acta Paediatr Suppl. 1996 May;412:3-9.
Esko K. et al. A Comparison of Diets with and without Oats in
Adults with Celiac Disease. N Engl J Med. 1995 Oct 19;333(16):1033-7
Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly
C, et al. Absence of oats toxicity in adult coeliac disease. BMJ
1996; 313: 1300-1301.
Reunala, T, Collin, P, Holm, K, Pikkarainen, P, Miettinen, A,
Vuolteenaho, N, Mäki, M (1998). Tolerance to oats in dermatitis
herpetiformis. Gut 43: 490-493.
Esko K. et al. A Comparison of Diets with and without Oats in
Adults with Celiac Disease. N Engl J Med. 1995 Oct 19;333(16):1033-7
Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O'Farrelly
C, et al. Absence of oats toxicity in adult coeliac disease. BMJ
1996; 313: 1300-1301.
Reunala, T, Collin, P, Holm, K, Pikkarainen, P, Miettinen, A,
Vuolteenaho, N, Mäki, M (1998). Tolerance to oats in dermatitis
herpetiformis. Gut 43: 490-493.
Troncone et al. Oat prolamines activate mucosal immune response
in the in vitro cultured treated coeliac mucosa (abstract du
congrès de l’ESPGAN, 4-8 juin 1996 à Munich, Allemagne). The
Journal of Pediatric Gastroenterology and Nutrition,1996;22:414